BSX

Boston Scientific Stock Analysis

AI Rating

Neutral
  • Quality9/10
  • Growth↑ 6/10
  • Momentum↓ 2/10
Boston Scientific sales and earnings growth
BSX Growth
Good
  • Revenue Y/Y↑ 19.87%
  • EPS Y/Y↑ 55.56%
  • FCF Y/Y↑ 38.30%
Boston Scientific gross and profit margin trends
BSX Profitability
Great
  • Gross margin ↑ 69.00%
  • EPS margin↑ 14.40%
  • ROIC↑ 16.90%
Boston Scientific net debt vs free cash flow
BSX Risk
Great
  • Debt / Equity↓ 0.5
  • Debt / FCF↓ 2.6
  • Interest coverage↑ 10.7

Boston Scientific stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗